Clinical Trial Update: Momelotinib Effectiveness in Myelofibrosis

View source ↗

Summary

This clinical trial update reports on the use of momelotinib for myelofibrosis, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Momelotinib (momelotinib)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Myelofibrosis (MF) | Status: NOT_YET_RECRUITING